Artivion | CRY - Loan Capital

Stock Price
37.76
Daily Change
0.60 1.61%
Monthly
4.54%
Yearly
58.39%
Q2 Forecast
36.95

Artivion reported $217.81M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
Accuray USD 127.32M 3.53M Sep/2025
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 217.81M 2.94M Dec/2025
AtriCure USD 61.86M 0 Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Boston Scientific USD 11.01B 19M Dec/2025
Edwards Lifesciences USD 600M 1.7M Mar/2026
Inogen USD 0 0 Jun/2022
Integra LifeSciences USD 1.86B 63.76M Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Orthofix International USD 174.45M 17.23M Dec/2025
Pfizer USD 57.41B 93M Sep/2025
ResMed USD 403.92M 4.74M Dec/2025
Stryker USD 14.86B 14M Dec/2025
Surmodics USD 29.67M 116K Jun/2025
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
Terumo JPY 99.9B 12M Dec/2025
Trinity Biotech USD 114.86M 4.81M Sep/2025